Overview
Generative protein design for therapeutic biologics.
Details
Generate uses generative AI to design novel proteins (antibodies, peptides) and has multiple programs in oncology and immunology. Major partnership with Amgen ($2B+).
Generative protein design for therapeutic biologics. Generate uses generative AI to design novel proteins (antibodies, peptides) and has multiple programs in oncology and immunology. Major partnership with Amgen ($2B+).
Generative protein design for therapeutic biologics.
Generate uses generative AI to design novel proteins (antibodies, peptides) and has multiple programs in oncology and immunology. Major partnership with Amgen ($2B+).